Behind Vaccine Stock Moderna’s Bearish Rating
Moderna stock rating: The COVID-19 vaccine maker’s stock has skyrocketed in the past year — but it scores a “bearish” rating. Here’s why.
Posted by Charles Sizemore | Mar 23, 2021 | Investing
Moderna stock rating: The COVID-19 vaccine maker’s stock has skyrocketed in the past year — but it scores a “bearish” rating. Here’s why.
Posted by Charles Sizemore | Mar 20, 2021 | Investing
In case you missed it, the Federal Reserve made waves this past week. That raises the question: Is it time to buy bitcoin or gold?
Posted by Charles Sizemore | Mar 19, 2021 | Investing
As the U.S. government attempts to lift the nation’s economy out of a recession, infrastructure spending and construction are set to spike. Commodity companies like aluminum manufacturer Norsk Hydro (OTC: NHYDY) are primed for gains in the next few years.
Posted by Charles Sizemore | Mar 18, 2021 | Personal Finance
Sometimes when investing, it’s best to keep it simple. That’s why we employ certain systems and try our best to avoid easy mistakes.
Posted by Charles Sizemore | Mar 17, 2021 | Investing
Kinder Morgan Inc. (NYSE: KMI) has had it rough, but it’s worked to become a more solid investment for your dividend portfolio in 2021.
Our experts do the work to make investing safe and profitable for you. Sign up for FREE access to our Money & Markets Daily daily emails and take control of the Markets!
Enter your username and password below